Treatment for lung metastasis from head and neck squamous cell carcinoma: A preliminary study of docetaxel

Oral and Maxillofacial Surgery

Volumn 12, Issue 1, 2008, Pages 13-18

  Yamagata, Kenji ^a   Onizawa, Kojiro ^a   Otsuka, Yuki ^a   Yoshida, Hiroshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Docetaxel (DOC); Head and neck squamous cell carcinoma (HANSCC); Lung metastasis; Overall survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; TAXOID;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG TOLERANCE; EVALUATION; FEMALE; HEAD AND NECK TUMOR; HUMAN; KAPLAN MEIER METHOD; LEUKOPENIA; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; NEUTROPENIA; PATHOLOGY; PILOT STUDY; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DRUG TOLERANCE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKOPENIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; PILOT PROJECTS; PROGNOSIS; RETROSPECTIVE STUDIES; TAXOIDS;

EID: 48949118721     PISSN: 18651550     EISSN: 18651569     Source Type: Journal    
DOI: 10.1007/s10006-008-0100-1     Document Type: Article

References (21)

1. Garavello W, Ciardo A, Spreafico R, Gaini RM (2006) Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132:762-766
2. de Bree R, Deurloo EE, Snow GB, Leemans CR (2000) Screening for distant metastases in patients with head and neck cancer. Laryngoscope 110:397-401
3. Leon X, Quer M, Orus C, del Prado Venegas M, Lopez M (2000) Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22:680-686
4. Alvi A, Johnson JT (1997) Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck 19:500-505
5. Troell RJ, Terris DJ (1995) Detection of metastases from head and neck cancers. Laryngoscope 105:247-250
6. Shingaki S, Suzuki I, Kobayashi T, Nakajima T (1996) Predicting factors for distant metastases in head and neck carcinomas: An analysis of 103 patients with locoregional control. J Oral Maxillofac Surg 54:853-857
7. Betka J (2001) Distant metastases from lip and oral cavity cancer. ORL J Otorhinolaryngol Relat Spec 63:217-221
8. Calhoun KH, Fulmer P, Weiss R, Hokanson JA (1994) Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 104:1199-1205
9. Liu D, Labow DM, Dang N, Martini N, Bains M, Burt M, et al. (1999) Pulmonary metastasectomy for head and neck cancers. Ann Surg Oncol 6:572-578
10. Hennemann B (2006) Palliative chemotherapy of head and neck cancer: present status and future development. Laryngorhinootologie 85:172-178 (article in German)
11. Bissery MC, Guenard D, Gueritte-Voegelein F, Lavelle F (1991) Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51:4845-4852
12. Braakhuis BJ, Kegel A, Welters MJ (1994) The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts. Cancer Lett 81:151-154
13. Chu Q, Vincent M, Logan D, Mackay JA, Evans WK (2005) Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline. Lung Cancer 50:355-374
14. Kurita H, Yamamoto E, Nozaki S, Wada S, Furuta I, Kurashina K (2004) Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma. Oral Oncol 40:1000-1006
15. Dreyfuss AI, Clark JR, Norris CM, Rossi RM, Lucarini JW, Busse PM, et al. (1996) Docetaxel: An active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 14:1672-1678
16. Catimel G, Verweij J, Mattijssen V, Hanauske A, Piccart M, Wanders J, et al. (1994) Docetaxel (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol 5:533-537
17. Couteau C, Chouaki N, Leyvraz S, Oulid-Aissa D, Lebecq A, Domenge C, et al. (1999) A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck. Br J Cancer 81:457-462
18. Ebihara S, Fujii H, Sasaki Y (1997) A late phase II study of docetaxel (Taxotere) in patients with head and neck cancer (HNC). Proc Am Soc Clin Oncol 16:399a Abstr 1425
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
20. Arbuck S, Ivy S, Setser A (1998) The Revised Common Toxicity Criteria: Version 2.0. CTEP. Website. http://ctep.info.nih.gov.
21. Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, et al. (2003) Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185:278-284